Literature DB >> 4045501

The effect of oral corticosteroid dosage on CT enhancing multiple sclerosis plaques.

R A Troiano, M P Hafstein, G Zito, M I Ruderman, P C Dowling, S D Cook.   

Abstract

Fifty high-dose delayed CT scans were performed on 36 patients with definite MS within 4 months of a clinical relapse. The number of enhancing lesions visualized was compared in patients being treated with high- or low-dose oral corticosteroids and untreated controls. High-dose oral corticosteroid treatment significantly but incompletely reduced enhancement of MS plaques. Lower doses were less effective, especially when the latter were given on alternate days.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4045501     DOI: 10.1016/0022-510x(85)90188-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  One-year MR imaging follow-up of patients with multiple sclerosis under cortisone therapy.

Authors:  D Uhlenbrock; E Herbe; D Seidel; W Gehlen
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

Review 2.  Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.

Authors:  D E Goodkin
Journal:  West J Med       Date:  1994-09

Review 3.  Imaging characteristics of toxoplasmosis encephalitis after bone marrow transplantation: report of two cases and review of the literature.

Authors:  C Mueller-Mang; T G Mang; P Kalhs; M M Thurnher
Journal:  Neuroradiology       Date:  2005-11-10       Impact factor: 2.804

Review 4.  Current pharmacologic treatment of multiple sclerosis symptoms.

Authors:  P B Andersson; D E Goodkin
Journal:  West J Med       Date:  1996-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.